ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 321239 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 321239; 2) Community: the network communities that were significantly associated with the response to NSC 321239; 3) Molecule: the relationships between components within communities and NSC 321239; 4) MDR: the compounds that were significantly associated with the NSC 321239.

NSC Compound Enrichment Correlation
NSC 303861 L-Cysteine analog 0.0403978426119736 0.421037
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0403978426119736 0.18109935
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.040397842611974 -0.082953172
NSC 339137 PHYSALOLACTONE 0.0403978426119741 0.31885403
NSC 349622 Cytovaricin 0.0403978426119741 -0.073014835
NSC 371777 Null 0.0403978426119741 0.22801238
NSC 55236 Null 0.0403978426119741 0.17249871
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0403978426119741 0.33625643
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0403978426119741 0.23674409
NSC 624657 ANTINEOPLASTIC-624657 0.0403978426119741 0.23514613
Total:110  Current:95    [First] [Prev] [Next] [Last]